FDA Releases Six New Draft Guidances on Gene Therapy

On 7/11/2018 FDA Commissioner, Scott Gottlieb, announced the release of six new draft guidance documents related to gene therapy development. In the announcement, Gottlieb acknowledged the accelerating pace of development and highlighted the FDA's role in both aiding development and ensuring safety.